Advanced search
Publication Cover
Leukemia & Lymphoma Volume 45, 2004 - Issue 2
Submit an article Journal homepage
67
Views
43
CrossRef citations to date
0
Altmetric
Original Article

Monoclonal Antibodies in the Treatment of Chronic Lymphoid Leukemias

TADEUSZ ROBAK Department of Hematology, Medical University of Łódź, Copernicus Memorial Hospital, 93-513 Łódź, ul. Pabianicka 62, PolandCorrespondence[email protected]
Pages 205-219 | Received 25 Apr 2003, Published online: 03 Aug 2009

Citations (43)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (9)

Tadeusz Robak. (2008) Alemtuzumab for B-cell chronic lymphocytic leukemia. Expert Review of Anticancer Therapy 8:7, pages 1033-1051.
Read now
Constantin A Dasanu. (2008) Intrinsic and treatment-related immune alterations in chronic lymphocytic leukaemia and their impact for clinical practice. Expert Opinion on Pharmacotherapy 9:9, pages 1481-1494.
Read now
Tadeusz Robak. (2008) Emerging drugs for rarer chronic lymphoid leukemias. Expert Opinion on Emerging Drugs 13:1, pages 95-118.
Read now
Mohamed A Kharfan-Dabaja, Rabih Fahed, Mohamad Hussein & Edgardo S Santos. (2007) Evolving role of monoclonal antibodies in the treatment of chronic lymphocytic leukemia. Expert Opinion on Investigational Drugs 16:11, pages 1799-1815.
Read now
Ewa Robak & Tadeusz Robak. (2007) Skin lesions in chronic lymphocytic leukemia. Leukemia & Lymphoma 48:5, pages 855-865.
Read now
Paweł Robak, Anna Linke, Barbara Cebula, Tadeusz Robak & Piotr Smolewski. (2006) Cytotoxic effect of R-etodolac (SDX-101) in combination with purine analogs or monoclonal antibodies on ex vivo B-cell chronic lymphocytic leukemia cells. Leukemia & Lymphoma 47:12, pages 2625-2634.
Read now
Suneel Mundle & Yelina Noskina. (2005) Cytogenetic testing for therapeutic indication in cancer. Expert Review of Molecular Diagnostics 5:1, pages 23-29.
Read now
Piotr Smolewski, Anna Szmigielska-Kaplon, Barbara Cebula, Krzysztof Jamroziak, Małgorzata Rogalinska, Zofia Kilianska & Tadeusz Robak. (2005) Proapoptotic activity of alemtuzumab alone and in combination with rituximab or purine nucleoside analogues in chronic lymphocytic leukemia cells. Leukemia & Lymphoma 46:1, pages 87-100.
Read now
Tadeusz Robak. (2004) Second Malignancies and Richter's Syndrome in Patients with Chronic Lymphocytic Leukemia. Hematology 9:5-6, pages 387-400.
Read now

Articles from other publishers (34)

Rohan G. Shinde, Vipul P. Patel, Shwetarani D. Gundgole, Suchita S. Dhumale & Snehal D. Dhole. (2022) A Current Review of Systemic Lupus Erythematosus Treatment Using Monoclonal Antibodies. Current Biotechnology 11:1, pages 27-31.
Crossref
Naval Daver, Aziz Nazha, Hagop M. Kantarjian, Rodney Haltom & Farhad Ravandi. (2013) Treatment of Hairy Cell Leukemia During Pregnancy: Are Purine Analogues and Rituximab Viable Therapeutic Options. Clinical Lymphoma Myeloma and Leukemia 13:1, pages 86-89.
Crossref
Tadeusz Robak. (2013) Emerging monoclonal antibodies and related agents for the treatment of chronic lymphocytic leukemia. Future Oncology 9:1, pages 69-91.
Crossref
Neerav Shukla, Rachel Kobos, Thomas Renaud, Julie Teruya‐Feldstein, Anita Price, Linda McAllister‐Lucas & Peter Steinherz. (2011) Successful treatment of refractory metastatic histiocytic sarcoma with alemtuzumab. Cancer 118:15, pages 3719-3724.
Crossref
Nermeen Ahmed El DesoukeyReham Abd Aleem AfifyDalia Gamil AminRasha Faragaly Mohammed. (2023) CD200 Expression in B-Cell Chronic Lymphoproliferative Disorders. Journal of Investigative Medicine 60:1, pages 56-61.
Crossref
I. García-Escobar, J. Sepúlveda, D. Castellano & H. Cortés-Funes. (2011) Therapeutic management of chronic lymphocytic leukaemia. Critical Reviews in Oncology/Hematology 80:1, pages 100-113.
Crossref
Tim Illidge & Franck Morschhauser. (2011) Radioimmunotherapy in follicular lymphoma. Best Practice & Research Clinical Haematology 24:2, pages 279-293.
Crossref
Tadeusz Robak. (2011) Hairy-cell leukemia variant: Recent view on diagnosis, biology and treatment. Cancer Treatment Reviews 37:1, pages 3-10.
Crossref
Holly M. Horton, Matthew J. Bernett, Matthias Peipp, Erik Pong, Sher Karki, Seung Y. Chu, John O. Richards, Hsing Chen, Roland Repp, John R. Desjarlais & Eugene A. Zhukovsky. (2010) Fc-engineered anti-CD40 antibody enhances multiple effector functions and exhibits potent in vitro and in vivo antitumor activity against hematologic malignancies. Blood 116:16, pages 3004-3012.
Crossref
Y. Uzunhan, J. Cadranel, N. Boissel, C. Gardin, B. Arnulf & A. Bergeron. (2010) Les manifestations pulmonaires spécifiques des hémopathies myéloïdes aiguës et des hémopathies lymphoïdes et lymphoplasmocytaires. Partie II : les manifestations pulmonaires spécifiques des hémopathies lymphoïdes et lymphoplasmocytaires (hors lymphomes). Revue des Maladies Respiratoires 27:6, pages 599-610.
Crossref
Carlos Cassano, Swetlana Mactier, Stephen P. Mulligan, Larissa Belov, Pauline Huang & Richard I. Christopherson. (2010) Cladribine and Fludarabine Nucleoside Change the Levels of CD Antigens on B-Lymphoproliferative Disorders. International Journal of Proteomics 2010, pages 1-9.
Crossref
Andrei Ivanov, Ruth Swann & Tim Illidge. (2008) New insights into the mechanisms of action of radioimmunotherapy in lymphoma. Journal of Pharmacy and Pharmacology 60:8, pages 987-998.
Crossref
Tadeusz Robak, Krzysztof Jamroziak & Pawel Robak. (2009) Current and Emerging Treatments for Chronic Lymphocytic Leukaemia. Drugs 69:17, pages 2415-2449.
Crossref
Anne L. Angiolillo, Alice L. Yu, Gregory Reaman, Ashish M. Ingle, Rita Secola & Peter C. Adamson. (2009) A phase II study of Campath‐1H in children with relapsed or refractory acute lymphoblastic leukemia: A Children's Oncology Group report. Pediatric Blood & Cancer 53:6, pages 978-983.
Crossref
Tadeusz Robak. (2009) Ofatumumab for the treatment of chronic lymphocytic leukemia. Therapy 6:4, pages 577-587.
Crossref
Sara Huerta-Yepez, Mario Vega, Saul E. Escoto-Chavez, Benjamin Murdock, Toshiyuki Sakai, Stavroula Baritaki & Benjamin Bonavida. (2009) Nitric oxide sensitizes tumor cells to TRAIL-induced apoptosis via inhibition of the DR5 transcription repressor Yin Yang 1. Nitric Oxide 20:1, pages 39-52.
Crossref
Thomas Elter, Janne J. Vehreschild, John Gribben, Oliver A. Cornely, Andreas Engert & Michael Hallek. (2008) Management of infections in patients with chronic lymphocytic leukemia treated with alemtuzumab. Annals of Hematology 88:2, pages 121-132.
Crossref
Roger S. Riley, David Williams, Micaela Ross, Shawn Zhao, Alden Chesney, Bradly D. Clark & Jonathan M. Ben‐Ezra. (2009) Bone marrow aspirate and biopsy: a pathologist's perspective. II. interpretation of the bone marrow aspirate and biopsy. Journal of Clinical Laboratory Analysis 23:5, pages 259-307.
Crossref
Tadeusz Robak. (2008) Treatment of chronic lymphoid leukemias with monoclonal antibodies: current place and perspectives. Drug Development Research 69:7, pages 373-387.
Crossref
Tim IllidgeMike Bayne. 2008. Treatment of Cancer Fifth Edition. Treatment of Cancer Fifth Edition 203 225 .
Tadeusz Robak. (2007) Recent progress in the management of chronic lymphocytic leukemia. Cancer Treatment Reviews 33:8, pages 710-728.
Crossref
Tadeusz Robak, Piotr Smolewski, Barbara Cebula, Olga Grzybowska-Izydorczyk & Jerzy Z. Błoński. (2007) Rituximab plus cladribine with or without cyclophosphamide in patients with relapsed or refractory chronic lymphocytic leukemia. European Journal of Haematology 79:2, pages 107-113.
Crossref
A. Süß, T. Wetzig, M. Sticherling, A. Tannapfel & J. C. Simon. (2006) Mycosis fungoides und chronisch lymphatische B-Zell-LeukämieMycosis fungoides and B-cell chronic lymphocytic leukemia. Der Hautarzt 57:10, pages 888-892.
Crossref
Tadeusz Robak, Piotr Smolewski, Barbara Cebula, Anna Szmigielska‐Kaplon, Krzysztof Chojnowski & Jerzy Z. Blonski. (2006) Rituximab combined with cladribine or with cladribine and cyclophosphamide in heavily pretreated patients with indolent lymphoproliferative disorders and mantle cell lymphoma. Cancer 107:7, pages 1542-1550.
Crossref
Elaine J. Coleman, Kimberly J. Brooks, Joan E. Smallshaw & Ellen S. Vitetta. (2006) The Fc Portion of UV3, an Anti-CD54 Monoclonal Antibody, Is Critical for its Antitumor Activity in SCID Mice With Human Multiple Myeloma or Lymphoma Cell Lines. Journal of Immunotherapy 29:5, pages 489-498.
Crossref
Livio PaganoMorena CairaLuana FianchiGiuseppe Leone. (2006) Acute lymphoblastic leukemia in elderly patients: clinical characteristics, treatment and outcome. Aging Health 2:1, pages 123-133.
Crossref
John R. McWhirter, Anke Kretz-Rommel, Alan Saven, Toshiaki Maruyama, Kathleen N. Potter, C. Ian Mockridge, E. Prenn Ravey, Fenghua Qin & Katherine S. Bowdish. (2006) Antibodies selected from combinatorial libraries block a tumor antigen that plays a key role in immunomodulation. Proceedings of the National Academy of Sciences 103:4, pages 1041-1046.
Crossref
Che-Leung Law, Kristine A. Gordon, John Collier, Kerry Klussman, Julie A. McEarchern, Charles G. Cerveny, Bruce J. Mixan, Wyne P. Lee, Zhonghau Lin, Patricia Valdez, Alan F. Wahl & Iqbal S. Grewal. (2005) Preclinical Antilymphoma Activity of a Humanized Anti-CD40 Monoclonal Antibody, SGN-40. Cancer Research 65:18, pages 8331-8338.
Crossref
Janice MY Brown. (2005) Exogenous administration of immunomodulatory therapies in hematopoietic cell transplantation: an infectious diseases perspective. Current Opinion in Infectious Diseases 18:4, pages 352-358.
Crossref
Tadeusz Robak. (2005) Therapy of chronic lymphocytic leukemia with purine analogs and monoclonal antibodies. Transfusion and Apheresis Science 32:1, pages 33-44.
Crossref
Tadeusz Robak. (2005) Alemtuzumab in the Treatment of Chronic Lymphocytic Leukemia. BioDrugs 19:1, pages 9-22.
Crossref
Tadeusz Robak. (2005) Rituximab Plus Purine Nucleoside Analogs in the Treatment of Indolent Lymphoid Malignancies. American Journal of Cancer 4:5, pages 279-292.
Crossref
Tadeusz Robak. (2004) Monoclonal antibodies in the treatment of autoimmune cytopenias. European Journal of Haematology 72:2, pages 79-88.
Crossref
Tadeusz Robak. (2004) Acute Lymphoblastic Leukaemia in Elderly Patients. Drugs & Aging 21:12, pages 779-791.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.